Latest Breaking News On - Trauma at harborview medical centre - Page 1 : comparemela.com

The US Food and Drug Administration (FDA) has awarded medical device start-up Opticyte for its Cell O2 Patient Monitor that provides real-time, continuous monitoring of patients at risk of organ failure.

Eileen bulgerLori arakakiTrauma at harborview medical centreDrug administrationBreakthrough device designationHarborview medical centreDisease control